Ir para o conteúdo principal

Alphatec (NASDAQ: ATEC) — Perfil da empresa, notícias e dados financeiros

Logo de Alphatec
ATEC Alphatec
Alphatec primary media
Perfil da empresa

Alphatec

Alphatec (NASDAQ:ATEC) is a company focused on the design, development, and marketing of products for the surgical treatment of spine disorders. With a commitment to improving patient outcomes, Alphatec's portfolio includes a wide range of solutions aimed at addressing the challenges faced by spine surgery professionals. Projects encompass innovative spinal fusion technologies, minimally invasive surgery techniques, and biologics, aiming to advance spinal care and enhance quality of life for patients. The company's objectives revolve around expanding its market presence, continually innovating its product line, and maintaining a strong focus on customer satisfaction and clinical excellence. Through rigorous research and development, Alphatec seeks to lead the way in providing state-of-the-art spine care solutions.

Resumo

Public USParticipação acionária
1990Ano de fundação
896Funcionários
Carlsbad, United StatesSede
Carregando mapa...
Presença global

Operações

Todos os locais
Carlsbad, US

Produtos e/ou serviços de Alphatec

  • Spinal fusion technologies designed to enhance patient outcomes and surgeon experience.
  • Minimally invasive surgery tools for improved precision and recovery in spinal procedures.
  • 3D-printed interbody implants for enhanced spinal fusion and bone growth.
  • Comprehensive spine surgery planning and navigation software for accurate implant placement.
  • Advanced biologics for spinal fusion enhancement and bone healing acceleration.
  • Patient-specific spinal instrumentation and implants for personalized surgery approaches.

equipe executiva do Alphatec

  • Patrick S. MilesChairman, CEO & President
  • J. Todd KoningExecutive VP & CFO
  • Scott LishChief Operating Officer
  • David P. SponselExecutive Vice President of Sales
  • Craig E. HunsakerExecutive Vice President of People & Culture
  • Robert JuddVP of Finance and Investor Relations & Controller
  • Tyson Eliot MarshallGeneral Counsel & Corporate Secretary
  • Ali ShorooghiSenior Vice President of Marketing & Medical Education
  • Jonathan AllenExecutive Vice President of Commercial Operations
  • Luiz PimentaChief Medical Officer

Principais indicadores financeiros

Resultados divulgados pela Alphatec, em USD.

Cap. de mercado
1,8 bi
Receita (TTM)
815,1 mi
P/L
—
LPA (diluído, TTM)
-0.7
Dividend yield
—
Margem de lucro
-13.5%
Receita e lucro anuais da Alphatec
Fim do ano fiscalReceitaResultado operacionalLucro líquido
764,2 mi-82,1 mi-143,4 mi
611,6 mi-136,2 mi-162,1 mi
482,3 mi-173,4 mi-186,6 mi
350,9 mi-147 mi-151,3 mi